Literature DB >> 15684336

Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.

Naohiro Sakata1, Yoshinobu Hoshii, Tomomi Nakamura, Makiko Kiyama, Hirofumi Arai, Masatoshi Omoto, Mitsunori Morimatsu, Tokuhiro Ishihara.   

Abstract

Apolipoprotein AI (apoAI), a major component of high-density lipoproteins, is one of the major amyloid fibril proteins and a minor constituent of the senile plaques observed in Alzheimer's disease. We examined colocalization of apoAI in various kinds of systemic amyloidosis in this study. Forty-three of 48 formalin-fixed paraffin-embedded heart specimens with various forms of systemic amyloidosis reacted immunohistochemically with anti-human apoAI antibody. ApoAI was also detected in water-extracted amyloid material by immunoblotting. In addition, we observed colocalization of apoAI and murine amyloid A (AA) amyloidosis in human apoAI transgenic mice. This is the first report of colocalization of apoAI with amyloid deposits in various forms of human systemic amyloidosis and murine AA amyloidosis in human apoAI transgenic mice. ApoAI may not always be a major component of amyloid fibrils, even when it is present in systemic amyloid deposits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684336     DOI: 10.1369/jhc.4A6387.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  2 in total

1.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

2.  High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion.

Authors:  Dominic W Chung; Junmei Chen; Minhua Ling; Xiaoyun Fu; Teri Blevins; Scott Parsons; Jennie Le; Jeff Harris; Thomas R Martin; Barbara A Konkle; Ying Zheng; José A López
Journal:  Blood       Date:  2015-11-09       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.